Clinical Takeaway Cannabinoid formulations, particularly CBD-containing products, show measurable reductions in anxiety symptoms across multiple study designs, though effect sizes and optimal dosing vary considerably by formulation and disorder type. Evidence for...
Cannabinoids for Autism: Clinical Evidence & ASD Research
Clinical Takeaway Several randomized clinical trials have examined cannabis derivatives, including CBD-rich preparations, for core and associated symptoms of autism spectrum disorder, with findings suggesting potential benefits for behavioral challenges, anxiety, and...
Endocannabinoid System & Teen Anxiety: Clinical Evidence
Clinical Takeaway Adolescents with depression and anxiety symptoms show increased likelihood of initiating and escalating cannabis use over time, suggesting internalising disorders may drive substance use as a coping mechanism. Clinicians working...
`Endocannabinoid System Research: Athlete Mental Health`
Clinical Takeaway Retired professional athletes from high contact team sports such as football, rugby, and ice hockey face elevated rates of depression, anxiety, and cognitive concerns compared to the general population. Career...
`Endocannabinoid System & Athlete Mental Health Research`
Clinical Takeaway Retired professional athletes from high contact team sports face elevated rates of depression, anxiety, and other mental health challenges compared to the general population, with factors like repetitive head trauma,...
`Cannabinoids for Children: Clinical Evidence Reviewed`
Clinical Takeaway Current evidence on cannabinoids in pediatric patients spans 276 studies across multiple designs, capturing both plant-derived and pharmaceutical formulations used to treat medical conditions in children under 18. The research...
endocannabinoid system clinical research: athlete mental health
Clinical Takeaway Retired professional athletes from high contact team sports show notable rates of depression, anxiety, and other mental health challenges after leaving their sport. Factors such as head trauma history, loss...
Patient Protect launches to tackle discrimination against UK medical cannabis patients
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyMental HealthSafety Why This Matters Clinicians prescribing medical cannabis need to inform patients about Patient...
Patient Protect launches to tackle discrimination against UK medical cannabis patients
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyMental HealthSafety Why This Matters This initiative addresses a significant barrier to treatment adherence by...
Daily Digest: Last 24 Hours: Cannabis and Anxiety Risk in the Long Run — March 03, 2026
A synthesis of 1 recently added cannabis articles — key themes, clinical context, and Dr. Caplan’s take.